Xeris Biopharma Holdings, Inc. financial data

Symbol
XERS on Nasdaq
Location
Chicago, IL
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 02 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 196% % -1.4%
Quick Ratio 62% % 18%
Debt-to-equity -3474% % -115%
Return On Equity -5.3% % -102%
Return On Assets 0.16% %
Operating Margin 8.5% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 172,431,290 shares 7.7%
Common Stock, Shares, Outstanding 166,215,410 shares 11%
Entity Public Float $731,100,000 USD 118%
Common Stock, Value, Issued $17,000 USD 13%
Weighted Average Number of Shares Outstanding, Basic 160,425,198 shares 9.3%
Weighted Average Number of Shares Outstanding, Diluted 172,742,720 shares 18%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $291,845,000 USD 44%
Research and Development Expense $31,165,000 USD 22%
Operating Income (Loss) $24,896,000 USD 899%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $554,000 USD
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $111,042,000 USD 55%
Accounts Receivable, after Allowance for Credit Loss, Current $51,050,000 USD 26%
Inventory, Net $68,673,000 USD 43%
Assets, Current $240,313,000 USD 43%
Property, Plant and Equipment, Net $4,945,000 USD -11%
Operating Lease, Right-of-Use Asset $22,112,000 USD -2.4%
Intangible Assets, Net (Excluding Goodwill) $88,078,000 USD -11%
Goodwill $22,859,000 USD 0%
Other Assets, Noncurrent $5,220,000 USD -3.5%
Assets $383,527,000 USD 19%
Accounts Payable, Current $3,076,000 USD 34%
Employee-related Liabilities, Current $24,061,000 USD 23%
Accrued Liabilities, Current $33,155,000 USD 20%
Liabilities, Current $109,574,000 USD 9.1%
Deferred Income Tax Liabilities, Net $0 USD -100%
Operating Lease, Liability, Noncurrent $31,531,000 USD -5.2%
Other Liabilities, Noncurrent $8,398,000 USD 327%
Liabilities $369,838,000 USD 4.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax $25,000 USD 0%
Retained Earnings (Accumulated Deficit) $671,307,000 USD 0.08%
Stockholders' Equity Attributable to Parent $13,689,000 USD
Liabilities and Equity $383,527,000 USD 19%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $10,031,000 USD 51%
Net Cash Provided by (Used in) Financing Activities $3,137,000 USD -109%
Net Cash Provided by (Used in) Investing Activities $19,650,000 USD 55%
Common Stock, Shares Authorized 350,000,000 shares 0%
Common Stock, Shares, Issued 166,215,410 shares 11%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $13,181,000 USD -177%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $115,063,000 USD 52%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $184,845,000 USD -7.2%
Deferred Tax Assets, Gross $9,408,000 USD 54%
Operating Lease, Liability $37,763,000 USD -4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $554,000 USD
Lessee, Operating Lease, Liability, to be Paid $64,611,000 USD -8.6%
Property, Plant and Equipment, Gross $13,122,000 USD 2.3%
Operating Lease, Liability, Current $6,232,000 USD 2.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two $6,389,000 USD 2.5%
Lessee, Operating Lease, Liability, to be Paid, Year One $6,232,000 USD 2.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.119 pure 0%
Deferred Income Tax Expense (Benefit) $0 USD -100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $26,848,000 USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year Three $6,549,000 USD 2.5%
Deferred Tax Assets, Operating Loss Carryforwards $119,813,000 USD 2.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25,000,000 shares 0%
Unrecognized Tax Benefits $834,000 USD 17%
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,714,000 USD 2.5%
Operating Lease, Payments $6,080,000 USD 74%
Additional Paid in Capital $685,004,000 USD 6.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $10,843,000 USD 0%
Depreciation, Depletion and Amortization $315,000 USD -3.4%
Share-based Payment Arrangement, Expense $22,366,000 USD 22%
Interest Expense $27,425,000 USD 63%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%